Metropolis Healthcare schedules an investor group meeting with Nuvama Institutional Equities on April 17, 2026.
The event includes a tour of the company's Global Reference Laboratory in Kurla followed by a meeting.
Discussions will be based solely on publicly available information, with no unpublished price-sensitive information shared.
The intimation is made under SEBI Listing Regulations and is also available on the company's website.